1. Introduction {#sec0005}
===============

This case report is in line with the SCARE guidelines for surgical case reports \[[@bib0005]\]. Small bowel malignancy is an uncommon condition comprising no more than 2% of all tumors of the gastrointestinal tract. Its annual incidence is approximately 13.9 cases per million persons. Clinical presentation is often vague and nonspecific delaying diagnosis \[[@bib0010]\].

The treatment of small bowel adenocarcinomas (SBA) is primarily surgical with limited role in adjuvant therapy. Most cases commonly present as single tumors in elder patients; however, we present a rare case of multiple adenocarcinomas of the small bowel in a young patient treated in our academic private institution.

2. Presentation of the case {#sec0010}
===========================

A 16-year-old female without personal or family history of digestive diseases, cancer or genetic disorders presented to the emergency department. She complained of increasing diffuse abdominal pain over 12 h without nausea, vomiting, diarrhea or weight loss. She was afebrile, hemodinamically stable, with moderate diffuse abdominal tenderness and distention. A computerized tomography showed an intussusception of the small bowel without any other findings ([Fig. 1](#fig0005){ref-type="fig"}a and b).Fig. 1Abdominal CT with i.v contrast (a) axial and (b) coronal view that shows small bowel thickening associated with an intussusception.Fig. 1

The patient underwent laparoscopic exploration. There was no free fluid, liver lesions or carcinomatosis. A jejunum-ileum intussusception was seen and a small laparotomy was performed. Multiple small polypoid tumors in the jejunum were the cause of the intussusception and 25 cm of small bowel were resected including all the lesions in the specimen without an extended lymphadenectomy and an end-to-end anastomosis was performed ([Fig. 2](#fig0010){ref-type="fig"}).Fig. 2Resected segment of jejunum with different polypoid tumors that harbor adenocarcinoma.Fig. 2

Biopsy showed a mucinous adenocarcinoma, an epithelial tumor according the WHO classification of tumors of the small intestine, in 2 tumors of 4,3 cm and 3 cm and well-differentiated tubular adenocarcinoma in 10 tumors of 0,5 cm--1 cm. The tumors infiltrated up to the muscular layer without vascular or perineural penetration. All the tumors of the specimen resected had a wide free margin and one harvested lymph node was free of malignancy.

Afterwards, the patient was controlled with an upper digestive endoscopy that showed a 2,5 cm tumor in the third portion of the duodenum. Colonoscopy was normal. Capsule enteroscopy showed the same tumor at the duodenum, but another 5 in the jejunum and 1 in the ileum. The patient underwent a PET-CT that showed 5 hypercatabolic lesions from the duodenum to the ileum without suspicious lymphadenopathies or metastases ([Fig. 3](#fig0015){ref-type="fig"}a and b).Fig. 3a and b: PET-CT in axial and coronal views that shows two hypermetabolic foci in small bowel, one of them associated with an intussusception.Fig. 3

Pre-test genetic counseling was offered in order to investigate a genetic inherited etiology and to provide more information regarding medical management and future risks related cancers. Benefits, limitations and implications of the results were discussed and the patient consented to have testing for a panel of genes associated with early onset polyposis. Genetic testing was done at Invitae and the following genes were evaluated for sequence changes and exonic deletions/duplications: APC, BMPR1A, CDH1, EPCAM, MLH1, MSH2, MSH6, MUTYH, PMS2, PTEN, SMAD4, STK11, TP53. Test results were negative with no pathogenic changes detected in the genes analysed thru next generation sequencing. Therefore, the cause of the patient́s condition remains unknown. Caution should be taken in interpreting the results since a negative test result reduces but does not eliminate the possibility that the patient's condition has a genetic component.

She finally underwent open surgery with intraoperative enteroscopy and resection of all the remaining lesions of the duodenum and the small bowel with segmental resections and extended lymphadenectomy with primary anastomoses. Biopsy was positive for adenocarcinoma in six tumors, all positive lesions had well-differentiated tubular adenocarcinoma. The tumors infiltrated up the muscular layer without vascular or perineural penetration and without any compromise of lymph nodes. All tumor borders were free of malignancy and 46 harvested lymph nodes were negative. The patient was staged as T2N0M0 and the oncologic committee decided only follow-up. Control PET-CT after three years is negative for recurrence.

3. Discussion {#sec0015}
=============

SBA appears mainly in the sixth and seventh decade of life. The most common locations are the duodenum, followed by the jejunum and ileum. Predisposing factors include adenomas, Crohn disease, celiac sprue, Peutz-Jeghers syndrome, familial adenomatous polyposis (FAP), and hereditary non-polyposis colorectal cancer (HNPCC) \[[@bib0015],[@bib0020]\]. Some pathologic similarities have been identified between colorectal and small bowel adenocarcinoma suggesting similar genetic pathways in the adenoma-carcinoma sequence with mutations in the K-ras, p53 and mismatch repair genes \[[@bib0025]\].

Its clinical presentation is often of advanced disease and requires a high index of suspicion including abdominal pain, distension and palpable mass. There is an average delay in the diagnosis around 6--8 months, with most of the patients detected at an advanced stage \[[@bib0030]\]. They can also present with gastrointestinal bleeding and anemia, obstruction, nausea/vomiting, and weight loss \[[@bib0025],[@bib0030]\]. There are several diagnostic techniques used, including radiologic (CT, MRI, PET-CT) and endoscopic approaches (enteroscopy, videocapsule) that are usually combined for a more accurate evaluation and diagnosis.

The cornerstone of treatment remains surgical, ranging from segmental resections to Whipple procedure. Prognostic factors include advance age, male sex, high cancer stage, residual tumor, distal location and lymph node involvement, being the last the most important one. The 5-year survival is poor and depends on tumor stage: 50%--60% for stage I, 39%--55% for stage II, 10%--40% for stage III and 3%--5% for stage IV \[[@bib0035]\]. The benefit of adjuvant therapy is unknown because of the nature of retrospective studies and relative small amount of patients receiving it. The most used chemotherapy regimen in the past was based in fluorouracil with modest results. Drugs like oxaliplatin and capecitabine are showing better outcome and a prospective international randomized trial (BALLAD) is being carried to assess its efficacy \[[@bib0035]\]. Radiotherapy has been described in cases of duodenal tumors with positive margins.

4. Conclusion {#sec0020}
=============

Multiple SBA is a rare condition with only few reports in the literature \[[@bib0040], [@bib0045], [@bib0050], [@bib0055], [@bib0060], [@bib0065]\]. Most of these cases occurs in elder patients and some of them associated with known risk factors. Our case differs in the young age of the patient and lack of known predisposing factors that might explain its appearance. Multiple diagnostic studies were used to determine the exact location and quantity of lesions before definitive treatment, showing that there isn't one single study to accurately stage the patient. Surgery with segmental resections was consider the main treatment leaving adjuvant therapy due to the lack of poor prognostic factors and lack of real benefit opting for an expectant management.

Conflicts of interest {#sec0025}
=====================

The authors have no conflict of interests.

Funding source {#sec0030}
==============

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Ethical approval {#sec0035}
================

Our institution has exempted ethical approval. We have informed consent of the patient for the presentation of this case.

Consent {#sec0040}
=======

Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request.

Author contribution {#sec0045}
===================

Cavalla C, Oppliger F surgeons and designed the report.

Castiblanco A, performed the histopathology analysis.

Margarit S performed the genetic analysis.

Valderrama R. gastrointestinal physician, Schiappacasse G collected the patient's clinical data.

Oppliger F, Cavalla C analysed the data and wrote the paper.

Guarantor {#sec0050}
=========

Cristián Cavalla and Federico Oppliger.
